Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

22nd Century (XXII) Research & Development (2016 - 2026)

22nd Century's Research & Development history spans 16 years, with the latest figure at $105000.0 for Q4 2025.

  • On a quarterly basis, Research & Development fell 51.83% to $105000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $687000.0, a 39.36% decrease, with the full-year FY2025 number at $688000.0, down 39.28% from a year prior.
  • Research & Development hit $105000.0 in Q4 2025 for 22nd Century, down from $193000.0 in the prior quarter.
  • Over the last five years, Research & Development for XXII hit a ceiling of $1.9 million in Q2 2022 and a floor of -$777000.0 in Q4 2022.
  • Historically, Research & Development has averaged $590050.0 across 5 years, with a median of $557500.0 in 2023.
  • Biggest five-year swings in Research & Development: surged 25675.0% in 2021 and later tumbled 169.19% in 2022.
  • Tracing XXII's Research & Development over 5 years: stood at $1.1 million in 2021, then tumbled by 169.19% to -$777000.0 in 2022, then skyrocketed by 163.32% to $492000.0 in 2023, then plummeted by 55.69% to $218000.0 in 2024, then tumbled by 51.83% to $105000.0 in 2025.
  • Business Quant data shows Research & Development for XXII at $105000.0 in Q4 2025, $193000.0 in Q3 2025, and $227000.0 in Q2 2025.